Glyco Liver Profile

One blood test. The complete liver profile.

Inflammation, fibrosis, cirrhosis and hepatocellular carcinoma (HCC) risk.

One result. Four specific markers.

Glyco Liver Profile enables patient risk assessment, monitoring, diagnosis and 5-year prediction of hepatocellular carcinoma (HCC) development using four glycan biomarkers which together provide a clear insight into liver health.

The ultimate risk stratification tool for chronic liver disease

The Glyco Liver Profile is a unique, non-invasive test that provides the clinician with a full picture of liver health regardless of aetiology — all from a single blood sample.

This innovative test addresses the medical and economic costs of chronic liver disease — accounting for approximately 2% of deaths annually — streamlining patient stratification and risk assessment, and improving clinical management and treatment outcomes.

Streamline and reduce costs: one kit and serum sample allows you to consolidate screening — reducing time, life costs and complexity for you and patients
Stratify and manage patient care: our intuitive four-index results allow you to easily identify and manage patients early with a sensitive, specific profile
Predict and save lives: a proven and accurate prognostic method providing automated, long-term assessment for a more complete and consistent picture of disease progression